KLA insider update: Higgins' RSU vesting changes beneficial ownership
Rhea-AI Filing Summary
What happened: KLA's EVP & Chief Financial Officer, Bren D. Higgins, had restricted stock units (RSUs) vest on August 3 and August 4, 2025 from grants made in 2023 and 2022. Each vesting event represented 25% of the original grants and the company automatically withheld shares at vesting to cover required tax withholding.
Why it matters: This is a compensation-related event that increases the number of vested shares while reducing the number of shares delivered because some were withheld for taxes. The filing shows the fair market value used for withholding was the closing price on August 1, 2025 ($886.64), and reports beneficial ownership figures of 23,920.749 and 23,182.006 shares following the respective vestings.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine RSU vesting for the CFO; tax-withholding reduced delivered shares, no material change to control.
The Form 4 shows two scheduled RSU vesting events for Bren D. Higgins tied to grants from 2023 and 2022. Each event represented 25% of the original awards and resulted in automatic share withholding to satisfy tax obligations. The filing discloses specific withheld amounts (722.381 and 738.743 shares) and the fair market value used ($886.64). Reported beneficial ownership after the vestings is 23,920.749 and 23,182.006 shares. These are compensation-driven transactions and, based on the information provided, do not indicate stock sales or shifts in control.
TL;DR: Compensation disclosure consistent with standard governance practice; withholding for taxes disclosed clearly.
The filing documents standard equity compensation mechanics: scheduled RSU vesting and automatic withholding to cover tax obligations, with the FMV tied to the closing price on August 1, 2025. The disclosure lists the number of shares issuable upon vesting (including 14,703.912 and 13,213.912 shares referenced in the explanations) and the post-transaction beneficial ownership totals. There is no indication in the form of unusual related-party transactions or departures from expected grant terms based on the information provided.